News Quantified

NEO – neogenomics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Wall Street's Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets [TheStreet.com]

NeoGenomics (NEO) was upgraded by Leerink Partners from "market perform" to "outperform". They now have a $25.00 price target on the stock.

NeoGenomics (NEO) was upgraded by Benchmark Co. from "hold" to "buy".

NeoGenomics (NEO) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]

NeoGenomics (NEO) Q1 2026 Earnings Transcript [Yahoo! Finance]

-4.2%

BEAT

2.1%

BEAT

-7.4%

BEAT

-16.1%

BEAT

Leerink Partners

Leerink Partners

Form 10-Q NEOGENOMICS INC For: Mar 31

Form 8-K NEOGENOMICS INC For: Apr 28

Form DEFA14A NEOGENOMICS INC

Form ARS NEOGENOMICS INC For: Dec 31

Form DEF 14A NEOGENOMICS INC For: Dec 31

Top News Gainers

3/16 Form 4 NEOGENOMICS INC For: Mar 13 Filed by: JONES STEVEN C 14.5%

10/29 Q3/2019 9/30/2019 EPS 0.070 ZacksConsensus 0.040 ActVsEst 0.030 - Beat 11.0%

4/28 Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript [The Motley Fool] 10.9%

3/1 NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News] 5.9%

11/22 Form 4 NEOGENOMICS INC For: Nov 20 Filed by: JONES STEVEN C 5.2%

3/18 NeoGenomics, Inc. (NASDAQ: NEO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.1%

2/27 NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.1%

2/28 NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference 5.0%

5/22 Form 8-K NEOGENOMICS INC For: May 22 4.3%

10/3 NeoGenomics (NEO) Presents At Cantor Healthcare Conference - Slideshow [Seeking Alpha] 3.9%

Top News Decliners

4/29 NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes -13.0%

4/28 Form 8-K NEOGENOMICS INC For: Apr 28 -11.0%

4/3 NeoGenomics Integrates HALO(R) From Indica Labs -10.3%

2/27 Q4/2019 12/31/2019 EPS 0.100 ZacksConsensus 0.050 ActVsEst 0.050 - Beat -10.0%

4/21 NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Stephens. They set an "overweight" rating on the stock. -6.7%

5/20 Form 8-K NEOGENOMICS INC For: May 20 -5.8%

10/30 NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $27.00 to $29.00. They now have a "buy" rating on the stock. -5.6%

6/10 Form 4 NEOGENOMICS INC For: Jun 06 Filed by: Johnson Kevin C -5.3%

2/5 NeoGenomics Announces Leadership Appointments -5.2%

4/1 NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 -4.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day